Is fetuin-A a estrategias forex intradialytic hypotension risk factor in dialysis patients or a mere risk marker? Intradialytic hypotension remains the commonest complication of routine outpatient haemodialysis treatments.
Multifrequency bioimpedance allows assessment of body fluid volumes. Multifrequency bioimpedance can potentially monitor changes in extracellular volume during dialysis and may therefore help to reduce intradialytic hypotension. A PDF file should load here. Published by Oxford University Press on behalf of ERA-EDTA. John Booth, Jennifer Pinney, Andrew Davenport. The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance, Nephrology Dialysis Transplantation, 2011, 227-231, DOI: 10.
FRESENIUS MEDIC : Release according to Article 40, Section 1 of the . FRESENIUS MEDIC : FMC takes stake in Humacyte in bet on bioengineere. Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, and organizers are expecting more than 13,000 attendees, including more than 10,000 scientists and clinicians. The largest scientific gathering of kidney disease experts worldwide, Kidney Week is an opportunity for researchers to discuss important advances in the care of patients with kidney and related disorders. The Use of Crit-Line to Monitor and Quantify Fluid Removal Rates in Dialysis Patients During a Baseline Observational Period.
Ordish, RN, Paul Balter, MD, Paul M. Zabetakis, MD, Claudy Mullon, PhD and Jose A. Outcomes from a Multi-Center Catheter Reduction Collaborative Program. Alex Rosenblum, RN, CNN, Eduardo Lacson, Jr. MD, MPH, Jill Hall, RN, CNN, Shu-Fang Lin, MA, Raymond Hakim, MD, PhD.
MD, John Rogus, ScD, Peter Kotanko, MD, Nathan W. Fresenius Medical Care, Waltham, MA, and Renal Research Institute, New York, NY. Effect of Oral Nutritional Supplements on Mortality in Hemodialysis Patients. MD, MPH, Weiling Wang, MS, Barbara Zebrowski, RD, Michael Lazarus, MD, Raymond Hakim, MD, PhD. Hypoglycemia-Related Hospitalization in Diabetic Hemodialysis Patients. MD, MPH, Weiling Wang, MS, Michael Lazarus, MD, Mark Williams, MD. Fresenius Medical Care, Waltham, MA, and Joslin Diabetes Center, Boston, MA.